+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients



Efficacy of early treatment of cytomegalovirus infection by ganciclovir in renal transplant recipients



Transplantation Proceedings 22(4): 1813-1814




(PDF emailed within 1 workday: $29.90)

Accession: 031197770

Download citation: RISBibTeXText

PMID: 2167536


Related references

Prophylactic treatment of cytomegalovirus primary infection with ganciclovir in renal transplant recipients. Transplantation Proceedings 27(4): 2448-2448, 1995

The efficacy of oral versus intravenously administered ganciclovir in the pre-emptive treatment of cytomegalovirus antigenemia in renal transplant recipients. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 920A, September, 2001

Ganciclovir for cytomegalovirus infection in renal transplant recipients. Lancet 1(8631): 216-217, 1989

Long-term oral ganciclovir prophylaxis for prevention of cytomegalovirus infection and disease in cytomegalovirus high-risk renal transplant recipients. Transplantation 70(8): 1174-1180, 2000

Efficacy of ganciclovir in liver and kidney transplant recipients with severe cytomegalovirus infection. Transplantation 46(2): 229-234, 1988

Effect of prophylactic ganciclovir on cytomegalovirus infection in renal transplant recipients. Nephrology, Dialysis, Transplantation 8(9): 858-862, 1993

Ganciclovir therapy of symptomatic cytomegalovirus infection in renal transplant recipients. Nephrology, Dialysis, Transplantation 4(10): 906-910, 1989

Evaluation of ganciclovir resistance in cytomegalovirus infection of renal transplant recipients in Tehran. Transplantation Proceedings 47(4): 1140-1142, 2016

Ganciclovir pharmacokinetics and cytokine dynamics in renal transplant recipients with cytomegalovirus infection. Clinical Transplantation 15(5): 297-308, 2001

Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients. Transplant Infectious Disease 6(1): 3-9, 2004

Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients. Transplantation Proceedings 36(10): 3019-3024, 2005

Ganciclovir treatment for cytomegalovirus infections in renal transplant recipients. Transplantation Proceedings 24(5): 1921-1923, 1992

Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection. Journal of Medical Virology 73(4): 566-573, 2004

Treatment of active cytomegalovirus disease with oral ganciclovir in renal allograft recipients: monitoring efficacy with quantitative cytomegalovirus polymerase chain reaction. American Journal of Transplantation 2(7): 671-673, 2002

Use of leflunomide in renal transplant recipients with ganciclovir-resistant/refractory cytomegalovirus infection: a case series from the University of Chicago. Case Reports in Nephrology and Dialysis 5(1): 96-105, 2015